While the possible explanation includes a higher prevalence of obesity in patients with NAFLD, our results showed no differences in IL-6 concentrations between non-obese and obese NAFLD patients. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.